Last $63.60 USD
Change Today +0.05 / 0.08%
Volume 393.0K
OCR On Other Exchanges
Symbol
Exchange
New York
As of 8:04 PM 08/26/14 All times are local (Market data is delayed by at least 15 minutes).

omnicare inc (OCR) Snapshot

Open
$63.63
Previous Close
$63.55
Day High
$63.90
Day Low
$63.40
52 Week High
07/1/14 - $67.49
52 Week Low
10/23/13 - $52.26
Market Cap
6.2B
Average Volume 10 Days
617.5K
EPS TTM
$2.72
Shares Outstanding
97.9M
EX-Date
06/10/14
P/E TM
23.4x
Dividend
$0.80
Dividend Yield
1.16%
Current Stock Chart for OMNICARE INC (OCR)

omnicare inc (OCR) Related Businessweek News

View More BusinessWeek News

omnicare inc (OCR) Details

Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. It operates through two segments, Long-Term Care Group and Specialty Care Group. The company offers pharmaceuticals, and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. It also operates institutional pharmacy business serving skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other healthcare service providers; and provides pharmacy consulting services, including monthly patient drug therapy evaluations, assistance in compliance with state and federal regulations, as well as offers proprietary clinical and health management programs. In addition, the company provides a suite of technology solutions based on its Omniview Web-based platform as the electronic ordering of prescription refills, proof-of-delivery tracking, and real-time validation of Medicare Part D coverage; intravenous medications and nutrition products, respiratory therapy services, and clinical care planning services; and pharmaceutical case management services for retirees, employees, and dependents. Further, it offers specialty pharmacy and commercialization services for the biopharmaceutical industry; and provides brand support services, supply chain solutions, patient support services, and specialty pharmacy platforms. The company’s specialized drugs deal primarily with specific categories of drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology, and growth hormones. Omnicare, Inc. was founded in 1981 and is headquartered in Cincinnati, Ohio.

omnicare inc (OCR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $924.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $506.2K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $485.3K
Consultant
Total Annual Compensation: $1.3M
Compensation as of Fiscal Year 2013.

omnicare inc (OCR) Key Developments

Omnicare Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Revised Earnings Guidance for 2014

Omnicare Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, net sales were $1,610,584,000 against $1,503,116,000 last year. Operating income was $130,246,000 against $106,680,000 last year. Income from continuing operations before income taxes was $100,266,000 against $77,056,000 last year. Income from continuing operations was $61,246,000 or $0.58 per diluted share against $47,302,000 or $0.43 per diluted share last year. Net income was $21,971,000 or $0.21 per diluted share against $52,219,000 or $0.48 per diluted share last year. Net cash flows from operating activities was $218,882,000. Capital expenditures were $21,858,000. Adjusted cash earnings per diluted share from continuing operations were $0.91 against $0.85 last year. EBITDA from continuing operations was $157,393,000 against $133,991,000 last year. Adjusted EBITDA from continuing operations was $176,224,000 against $168,771,000 last year. For the six months, net sales were $3,181,622,000 against $2,962,061,000 last year. Operating income was $262,998,000 against $215,056,000 last year. Income from continuing operations before income taxes was $203,577,000 against $155,970,000 last year. Income from continuing operations was $124,884,000 or $1.17 per diluted share against $95,616,000 or $0.88 per diluted share last year. Net income was $85,745,000 or $0.80 per diluted share against $106,573,000 or $0.98 per diluted share last year. Net cash flows from operating activities was $396,380,000. Capital expenditures were $48,023,000. Adjusted cash earnings per diluted share from continuing operations were $1.82 against $1.69 last year. EBITDA from continuing operations was $317,750,000 against $268,287,000 last year. Adjusted EBITDA from continuing operations was $353,909,000 against $329,692,000 last year. Based upon its first half results, Omnicare updated its expectations for cash flows and reaffirmed other elements of its full year of 2014 guidance. The company expects revenue in the range of $6.3 billion to $6.4 billion against previous revenue guidance in the range of $6.3 billion to $6.4 billion. Adjusted cash earnings per diluted share (excluding special items) are expected to be in the range of $3.64 to $3.72 against previous guidance in the range of $3.64 to $3.72. Cash flows from operations (excluding settlement payments) is expected to be in the range of $500 million to $550 million against previous guidance in the range of $475 million to $550 million.

Omnicare Mulls Acquisitions

Omnicare Inc. (NYSE:OCR) is looking for acquisitions. Rocky Kraft, Senior Vice President of Finance and Chief Financial Officer of Omnicare Inc. said, "After we invest in the business appropriately and are opportunistic around any debt or acquisition opportunities, from there we will continue to return capital to shareholders."

Omnicare Inc. to Report Q2, 2014 Results on Jul 23, 2014

Omnicare Inc. announced that they will report Q2, 2014 results at 9:00 AM, US Eastern Standard Time on Jul 23, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCR:US $63.60 USD +0.05

OCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OCR.
View Industry Companies
 

Industry Analysis

OCR

Industry Average

Valuation OCR Industry Range
No financial data is available for OCR.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMNICARE INC, please visit www.omnicare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.